老年营养风险指数可预测头颈癌治疗不耐受与生存
这项双中心双向性研究纳入312例接受手术的初治头颈癌患者,按术前老年营养风险指数(GNRI)分为中高风险(<92)、低风险(92-98)和无风险(>98)。中高风险患者90天死亡率、治疗不耐受及总生存和無病生存均更差,GNRI可预测治疗不耐受和生存。
要点
- 术前GNRI<92与90天死亡率升高独立相关(OR 2.99)。
- GNRI中高风险者治疗不耐受风险增加(OR 2.35)。
- GNRI中高风险与更短的总生存和無病生存相关。
核心结论
- GNRI可预测可手术头颈癌患者的治疗不耐受和较差生存。
研究设计与样本
- 双向性研究,纳入两个学术中心2015-2024年接受头颈癌手术的患者312例。
- 术前GNRI分为中高风险(<92)、低风险(92-98)和无风险(>98)。
- 排除既往头颈癌或放疗史患者,采用多因素logistic和Cox回归调整年龄、CCI、肿瘤分期、原发部位和PEG状态。
主要发现
- 312例初治手术患者中,13%为中高GNRI风险,8%为低风险。
- 中高GNRI风险者主要不良事件发生率为57%,无风险者为36%。
- 中高GNRI风险者治疗不耐受率为61%,无风险者为41%。
- 中高GNRI风险者90天死亡率11%,无风险者4%(趋势)。
- 调整肿瘤部位和病理分期后,中高GNRI风险与90天死亡率(OR 2.99,95%CI 1.01-9.31;p=0.048)和治疗不耐受(OR 2.35,95%CI 1.21-4.56;p=0.012)相关。
关键数值与推荐
- GNRI中高风险定义为<92,低风险为92-98,无风险为>98。
- Cox回归显示中高GNRI风险与较短总生存(HR 2.28,95%CI 1.44-3.62;p<0.001)和無病生存(HR 1.87,95%CI 1.20-2.91;p=0.005)相关。
临床怎么用
- 术前可采用GNRI对头颈癌手术患者进行营养风险分层。
- 对GNRI<92的中高风险患者,应加强营养干预和术后监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Malnutrition is associated with worse outcomes in head and neck cancer (HNC). The geriatric nutritional risk index (GNRI) may predict postoperative morbidity and survival, but its role remains underexplored. METHODS: An ambispective study of patients undergoing HNC surgery at two academic centers (2015-2024) was performed. Preoperative GNRI was categorized into moderate-to-high risk (< 92), low risk (92-98), and no risk (> 98). Outcomes included 90-day mortality, treatment intolerance, overall survival, and disease-free survival. Analyses were performed using multivariable logistic and Cox regression adjusted for age, Charlson Comorbidity Index (CCI), tumor stage, primary tumor site, and percutaneous endoscopic gastrostomy (PEG) status. Patients with prior head and neck cancer or prior radiation were excluded. RESULTS: Among 312 treatment-naïve surgical patients, 13% were moderate-to-high GNRI risk and 8% low risk. Moderate-to-high GNRI risk had higher major adverse events (57% vs. 36% in no-risk), greater treatment intolerance (61% vs. 41%), and a trend toward higher 90-day mortality (11% vs. 4%). On multivariable models adjusted for tumor site and pathologic stage, moderate-to-high GNRI risk was associated with higher odds of 90-day mortality (OR 2.99, 95% CI 1.01-9.31; p = 0.048) and treatment intolerance (OR 2.35, 95% CI 1.21-4.56; p = 0.012). Cox regression showed shorter overall (HR 2.28, 95% CI 1.44-3.62; p < 0.001) and disease-free survival (HR 1.87, 95% CI 1.20-2.91; p = 0.005). CONCLUSIONS: The GNRI predicted treatment intolerance and poorer survival in patients with operable HNC.
引用
- Chowdhury R, Mlynarek AM, Richardson K, et al. Geriatric Nutritional Risk Index Predicts Treatment Intolerance and Survival in Head and Neck Cancer. Head Neck. 2025. PMID: 41257342. doi:10.1002/hed.70101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。